Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
With a market cap of 23.97B, Moderna(MRNA) trades at $60.63. The stock has a price-to-earnings ratio of -7.49.
On 2026-06-24, Moderna(MRNA) stock traded between a low of $59.85 and a high of $62.75. Shares are currently priced at $60.63, which is +1.3% above the low and -3.4% below the high.
Moderna(MRNA) shares are trading with a volume of 11.7M, against a daily average of 9.17M.
In the last year, Moderna(MRNA) shares hit a 52-week high of $67.74 and a 52-week low of $22.28.
In the last year, Moderna(MRNA) shares hit a 52-week high of $67.74 and a 52-week low of $22.28.
MRNA News
An FDA advisory committee previously voted unanimously to recommend approval of Moderna’s mRNA-based influenza vaccine, mFlusiva, for adults aged 50 and over, a...
Key Points Investors flocked to Moderna during early pandemic days as its coronavirus vaccine delivered blockbuster revenue. Since, times have been tough for...
Biotech and Pharma Moderna Stock’s 6-Day Rally Ends in a Dive. Why It’s One of the S&P 500’s Biggest Losers Today. In this article MRNA SPX Moderna stock rallie...
Analyst ratings
67%
of 27 ratingsMore MRNA News
Moderna ( (MRNA) ) has risen by 22.69%. Read on to learn why. Claim 55% Off TipRanks Unlock powerful investing tools and data-driven insights with TipRanks Prem...
Key Points Modera grew revenue by 260% year over year in the first quarter. The company is trying its mRNA platform in oncology vaccines. Moderna is looking...
The FDA’s Vaccines and Related Biological Products Advisory Committee, or VRBPAC, voted 9-0 that the benefits of Moderna’s investigational flu vaccine mRNA-1010...
The FDA plans to consider the committee’s recommendations as part of its ongoing review of Moderna’s biologics license application for mRNA-1010, Moderna said....
Moderna (MRNA) announced that the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted 9-0 that the benefits of...
Jefferies reiterated a Hold rating and $45 price target on Moderna (MRNA) after the FDA’s Advisory Committee voted 9-0 in favor of a full approval for Moderna’s...
Key Points Moderna is racing towards important clinical and regulatory catalysts. Krystal Biotech still has a large market to address in its core area. AMD i...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.